TTYA02

N/A

Report date: 2024/12/18 14:09:10

Base Information

Drug NameTTYA02
Drug Alias NameTTYA02
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector
Mechanisms of ActionLow affinity neurotrophin receptor p75NTR antagonists
TargetsLow affinity neurotrophin receptor p75NTR
Therapy Area/IndicationsAlzheimer DiseaseStrokeCerebral Palsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Auzone Biological Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Auzone Biological Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsAlzheimer DiseaseStrokeCerebral Palsy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A